Lynn Woo, MD

• Associate Professor of Urology, Cleveland Clinic Lerner College of Medicine Case Western Reserve University
• Associate Residency Program Director of Urology, Cleveland Clinic
• Society of Pediatric Urology Nominating Committee

• Castle Connolly Top Doctors – 5 years 2024
• Martin L. Resnick Excellence in Teaching Award 2023
• Best Doctors in America / Top Docs – Cleveland Magazine 2017-present
• YWCA Women of Professional Excellence Award 2013
• Society for Pediatric Urology (SPU) Research Grant Award 2009
• Silbar Award, North Central Section of the American Urological Association 2007
• Cleveland Clinic Innovator Award “Use of Stem Cell Homing Molecules for Treatment of Pelvic Organ Dysfunction” 2006
• Society for Urodynamics and Female Urology (SUFU) Resident Essay Award 2006
• Traveling Award for novel work on stem cell homing in a rat model of vaginal birth trauma at the Society of Female Urology and Voiding Program 2006
• Cleveland Clinic Foundation Research Program Committee Grant 2005
• Travel Award from Society for Urodynamics and Female Urology for pelvic organ cytokine expression in response to simulated childbirth injuries in rats 2005

See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.

As of 2026-03-20, Dr. Woo has reported no financial relationship with industry that is applicable to this listing.

In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.